Coronavirus poses a much higher risk to people living with pre-existing conditions and systemic inflammation. Now more than ever, it is imperative that we consider the role we play as true health care providers to support our patients to optimal oral and overall health.
With the many changes in our clinical practice for the foreseeable future, we must utilize any and all adjunctive therapies that can help reduce oral disease and inflammation.
During this discussion we will review aerosol management options and considerations, the critical role of adjunctive therapies such as bacterial testing, host modulation, oral probiotics and locally delivered antibiotics for better clinical outcomes.
Please click the PLAY button below to access the on-demand course.